1-11 of 11
Ben Van Camp
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Activation of ATF4 mediates unwanted Mcl-1 accumulation by proteasome inhibition

Jinsong Hu, Nana Dang, Eline Menu, Elke De Bryune, Dehui Xu, Ben Van Camp, Els Van Valckenborgh, Karin Vanderkerken
Journal: Blood
Blood (2012) 119 (3): 826–837.
https://doi.org/10.1182/blood-2011-07-366492
Published: 2012
Includes: Supplemental data
Journal Articles

Involvement of Dll1/Notch Interaction In MM Drug Resistance, Clonogenic Growth and In Vivo Engraftment

Dehui Xu, Jinsong Hu, Elke De Bruyne, Eline Menu, Ben Van Camp, Karin Vanderkerken, Els Van alckenborgh
Journal: Blood
Blood (2010) 116 (21): 2966.
https://doi.org/10.1182/blood.V116.21.2966.2966
Published: 2010
Journal Articles

Impaired Osteogenic Differentiation of Mesenchymal Stem Cells Derived From Multiple Myeloma Patients Is Associated with a Failure In the Deactivation of the NOTCH Pathway

Song Xu, Jinsong Hu, Dehui Xu, Isabelle Vande Broek, Xavier Leleu, Ben Van Camp, Karin Vanderkerken, Ivan Van Riet
Journal: Blood
Blood (2010) 116 (21): 1894.
https://doi.org/10.1182/blood.V116.21.1894.1894
Published: 2010
Journal Articles

Targeting the multiple myeloma hypoxic niche with TH-302, a hypoxia-activated prodrug

Brief Report
Jinsong Hu, Damian R. Handisides, Els Van Valckenborgh, Hendrik De Raeve, Eline Menu, Isabelle Vande Broek, Qian Liu, Jessica D. Sun, Ben Van Camp, Charles P. Hart, Karin Vanderkerken
Journal: Blood
Blood (2010) 116 (9): 1524–1527.
https://doi.org/10.1182/blood-2010-02-269126
Published: 2010
Includes: Supplemental data
Journal Articles

Hypoxia Activated Prodrug TH-302 for the Treatment of Multiple Myeloma.

Jinsong Hu, Damian R Handisides, Els Van Valckenborgh, Hendrik De Raeve, Eline Menu, Isabelle Vande Broek, Qian Liu, Jessica D Sun, Ben Van Camp, Charles Hart, Karin Vanderkerken
Journal: Blood
Blood (2009) 114 (22): 3838.
https://doi.org/10.1182/blood.V114.22.3838.3838
Published: 2009
Journal Articles

Decreased Thymosin Beta 4 Expression Results in Poor Prognosis and Decreased Survival in Multiple Myeloma.

Jo Caers, Dirk Hose, Ine Kuipers, Tomas Jan Bos, Els Van Valckenborgh, Eline Menu, Elke De Bruyne, Hartmut Goldschmidt, Ben Van Camp, Bernard Klein, Karin Vanderkerken
Journal: Blood
Blood (2008) 112 (11): 1703.
https://doi.org/10.1182/blood.V112.11.1703.1703
Published: 2008
Journal Articles

Regulation of Bim Expression by IGF-1 in the 5T33MM Murine Model for Multiple Myeloma.

Elke De Bruyne, Tomas Bos, Sarah Deleu, Peter Atadja, PhD, Eline Menu, PhD, Els Van Valckenborgh, PhD, Ben Van Camp, MD, PhD, Karin Vanderkerken, PhD
Journal: Blood
Blood (2007) 110 (11): 3512.
https://doi.org/10.1182/blood.V110.11.3512.3512
Published: 2007
Journal Articles

Inhibiting the IGF-1 receptor tyrosine kinase with the cyclolignan PPP: an in vitro and in vivo study in the 5T33MM mouse model

Eline Menu, Helena Jernberg-Wiklund, Thomas Stromberg, Hendrik De Raeve, Leonard Girnita, Olle Larsson, Magnus Axelson, Kewal Asosingh, Kenneth Nilsson, Ben Van Camp, Karin Vanderkerken
Journal: Blood
Blood (2006) 107 (2): 655–660.
https://doi.org/10.1182/blood-2005-01-0293
Published: 2006
Journal Articles

Inhibiting the IGF-1 Receptor Tyrosine Kinase with Picropodophillin: An In Vitro and In Vivo Study in the 5T33MM Mouse Model.

Karin Vanderkerken, PhD, Eline Menu, Thomas Stromberg, PhD, Hendrik De Raeve, MD, Kewal Asosingh, PhD, Ben Van Camp, MD, PhD, Helena Jernberg-Wiklund, PhD
Journal: Blood
Blood (2004) 104 (11): 640.
https://doi.org/10.1182/blood.V104.11.640.640
Published: 2004
Journal Articles

Osteoprotegerin inhibits the development of osteolytic bone disease in multiple myeloma

Peter I. Croucher, Claire M. Shipman, Jennifer Lippitt, Mark Perry, Kewal Asosingh, Anja Hijzen, Alex C. Brabbs, Edwin J. R. van Beek, Ingunn Holen, Timothy M. Skerry, Colin R. Dunstan, Graham R. Russell, Ben Van Camp, Karin Vanderkerken
Journal: Blood
Blood (2001) 98 (13): 3534–3540.
https://doi.org/10.1182/blood.V98.13.3534
Published: 2001
Journal Articles

Insulin-Like Growth Factor-1 Acts as a Chemoattractant Factor for 5T2 Multiple Myeloma Cells

Karin Vanderkerken, Kewal Asosingh, Filip Braet, Ivan Van Riet, Ben Van Camp
Journal: Blood
Blood (1999) 93 (1): 235–241.
https://doi.org/10.1182/blood.V93.1.235
Published: 1999